Sign up to save your podcasts
Or
Share Barbara Burtness, MD - Rethinking Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Promoting Apoptosis with Emerging Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Barbara Burtness, MD - Rethinking Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Promoting Apoptosis with Emerging Therapies
Please visit answersincme.com/XRU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in head and neck carcinoma discusses unmet therapeutic needs in squamous cell carcinoma of the head and neck and the potential impact of inhibitor of apoptosis proteins on treatment. Upon completion of this activity, participants should be better able to: Recognize the unmet therapeutic needs of patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN); Describe the rationale for targeting inhibitor of apoptosis proteins (IAPs) in the development of novel therapies for LA SCCHN; and Review the clinical impact of emerging IAP antagonists in the treatment of LA SCCHN, based on the preliminary efficacy and safety data.
View all episodes
By Answers in CME
5
55 ratings
Please visit answersincme.com/XRU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in head and neck carcinoma discusses unmet therapeutic needs in squamous cell carcinoma of the head and neck and the potential impact of inhibitor of apoptosis proteins on treatment. Upon completion of this activity, participants should be better able to: Recognize the unmet therapeutic needs of patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN); Describe the rationale for targeting inhibitor of apoptosis proteins (IAPs) in the development of novel therapies for LA SCCHN; and Review the clinical impact of emerging IAP antagonists in the treatment of LA SCCHN, based on the preliminary efficacy and safety data.
More shows like CME in Minutes: Education in Oncology & Hematology
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
325 Listeners
Journal of Clinical Oncology (JCO) Podcast
38 Listeners
This Week in Cardiology
862 Listeners
JAMA Clinical Reviews
493 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
JAMA Medical News
90 Listeners
CME in Minutes: Education in Cardiology & Pulmonology
3 Listeners
CME in Minutes: Education in Dermatology
3 Listeners
CME in Minutes: Education in Primary Care
5 Listeners
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
4 Listeners
CME in Minutes: Education in Ophthalmology
0 Listeners